Schedule a Meeting
Download Brochure
Table of Content
April 2025
The global bioresorbable polymers market size accounted for USD xx billion in 2024 and is predicted to increase from USD xx billion in 2025 to approximately USD xx billion by 2034, expanding at a CAGR of xx% from 2025 to 2034. Rising healthcare spending and advanced healthcare technologies increases demand of Bioresorbable polymer accelerate the market expansion.
Increasing demands in medical, pharmaceutical and environmental application contribute to market growth of Bioresorbable polymer. Bioresorbable polymers are chemically synthesized polymers that undergo bulk erosion and degrade under physiological condition, which are dissolved within the body. They are used in medical sector for various applications in surgical implants and medical devices including Interference screws, suture anchors, fracture plates, dental implants, and bone fixation devices. .It is used in drug delivery system to constant release of drug which improves patient convenience and therapeutic outcome. The increased usage of biodegradable materials in orthopedics drives the market.
Bioresorbable polymers, such as PLA and PGA, are used in orthopedic implants including screws, pins, and plates, which reduces need of second surgery and minimizes risk of infection. Advancement in technology like nanocomposites, 3D printing and electro spinning enhances their mechanical strength and biocompatibility which may boost bioresorbable polymers market growth in future.
| Report Attributes | Details |
| Market Size in 2025 | USD Billion |
| Expected Size in 2034 | USD Billion |
| Growth Rate | CAGR of % from 2025 to 2034 |
| Base Year of Estimation | 2024 |
| Forecast Period | 2025-2034 |
| Dominant Region | North America |
| Segment Covered | By Product, By Application, By Region |
| Key Companies Profiled | KLS Martin Group,3D Biotek LLC.,Sunstar Suisse S.A.,Corbion NV,Evonik Industries AG,Poly-Med Inc.,Foster Corp.,Abbott,DSM, Futerro |
Bioresorbable polymer are showing significant market opportunities in biomedical devices specifically in orthopedic devices and drug delivery system. Some bioresorbable polymers, like PLA (Polylactic acid), are used in the fabrication of dental implants, particularly for screws or plates. Due to its compatibility and biodegradability they are used in drug delivery system for target drug delivery and used in tissue engineering for soft tissue repair and bone generation. Due to increased healthcare infrastructure investment, rising surgical procedure and advancement in healthcare are showing significant future opportunities for bioresorbable polymers market.
Technological advancement like 3D printing and electro spinning presents significant market opportunities for bioresorbable polymer in biomedical field. 3D printing and electro spinning can be used to create micro- and nano-scale drug delivery systems with controlled release profiles to target specific cells. Also, the use of Bioresorbable polymer is used in wearable sensor for health monitoring, offers biodegradable ad biocompatible alternative to traditional material. Combining 3D printing and electro spinning enables the creation of intricate, multi-layered structures with enhanced properties like improved mechanical strength used in personalized treatment solution. Increased demand of this advanced technology may boost bioresorbable polymers market growth in future.
Due to high cost of raw material, complex polymerization process limits the growing market of Bioresorbable polymer. Biobased polymer which derived from renewable sources possess high raw material cost and it needs complex polymerization process may limit the market. Due to high cost, it makes them less competitive in price sensitive market and reduces their use in application. According to Environment Protection (EPR for Packaging) Rules, 2024, aim to ensure manufacturers and brand owners take responsibility for the entire lifecycle of their packaging, including disposal and recycling.
This could lead to increased costs for bioresorbable materials due to the need for stricter compliance, testing, and reporting requirement. Specifically in the medical device sector, the strict regulatory requirements for Bioresorbable devices, such as FDA approval, add to the overall development costs and can further hinder bioresorbable polymers market growth.
Due to limited scalability and only fewer production units limits the growth of the market. Due to lack of economies of scale leads to high manufacturing cost making them more expensive compared to the conventional plastics, this may limit future market growth.
North America dominated Bioresorbable polymers market in 2024, expected to grow during forecast period. Strong healthcare industry developed R & D and increased healthcare expenditure contributing to market growth in this region. In North America Bioresorbable polymers are used in drug delivery system and orthopedic application. Particularly in the US, drug delivery research and development increased demand of polymers, boost market growth.
The US and Canada have well established healthcare industry and major focus on research and development in pharmaceutical and medical device sector. Additionally, the healthcare spending in this region is very high which demands innovative medical devices and technologies. Combination of factor including strong healthcare industry, increasing healthcare expenditure and regulatory environment contribute to market growth in this region.
Asia Pacific is showing significant growth in bioresorbable polymers market in 2024 Asia-Pacific region has a strong healthcare industry including clinics and hospitals contributing to market growth. In this region increased geriatric population demands Bioresorbable polymers in application like orthopedic devices and drug delivery for serious condition. Due to increased n number of accidental cases most people suffer from ortho related diseases demand Bioresorbable polymers in orthopedic devices. Key countries in this region like China, India are driving the growth of market due to strong healthcare industry and economic growth. In Asia pacific region government are investing heavily on healthcare infrastructure boosting the Bioresorbable polymers in orthopedic devices.
The polylactic acid (PLA) segment held the dominating share of the bioresorbable polymers market in 2024. Polylactic acid (PLA) is made from renewable plant resources, contributing to a more sustainable production process compared to traditional plastics. The Polylactic acid (PLA) Have excellent biocompatibility, biodegradability, and versatility increasing demand in implant and fixation devices. It has strong mechanical properties and ability to thermoformed into various shapes so used in packaging industry.
Additionally, it has wider range of application including packaging, textiles, consumer goods, and medical devices. Increased demand for sustainable and eco-friendly packaging solutions drives the market growth of Polylactic acid (PLA) segment.
The polyglycolic acid segment is observed to grow at the fastest rate in the bioresorbable polymers market during the forecast period. Polyglycolic acid (PGA) is possess rapid degradation and is used in various applications including medical devices and tissue engineering. It is used in drug delivery, orthopedic implants absorbable suture, tissue engineering scaffolds, and biodegradable packaging alternatives.
It has strong physical and mechanical properties and can be degraded in the body through hydrolysis, making it safe for use in medical devices. So, versatility and suitability of polyglycolic acid segment in various applications may drive the market in future.
The orthopedics segment held the dominating share of the bioresorbable polymers market in 2024. Increasing demand of materials for bone fixation and implants contribute to market growth. Bioresorbable polymer like PLA and PLG are using widely because they offer strength and degrade over time which reduces need of secondary surgery. These polymers can provide mechanical support during the healing process, bone remodeling and regeneration. Wide range of application of Bioresorbable polymers in bone fixation device and surgical suture, drive the market. Increased demand of orthopedic care and efficient treatment without any surgical intervention may propel the market in upcoming years.
The drug delivery segment observed to grow at the fastest rate in the bioresorbable polymers market during the forecast period. Bioresorbable polymer is used in drug delivery system like sustained release and targeted delivery. Sustained release system using Bioresorbable polymer reduces need for frequent drug administration and improves patient compliance. These polymers used release drugs at specific locations within the body, which enhances treatment outcome , driving the market.
Product Launch: In July 2024, ZymoChem, announced the launch of BAYSE™, the scalable, 100% bio-based, and biodegradable Super Absorbent Polymer (SAP). BAYSE™ is made from renewable resources, readily biodegradable, lower carbon footprint, catering the environmental concerns.
By Product
By Application
By Region
April 2025
April 2025
April 2025
April 2025
Annual Access, Limitless Research! Unlock all market research reports with our annual subscription. Stay on top of market trends and crucial insights year-round!
2500+
Client Queries in 20235000+
Insights Published40+
Consulting Projects Per Year25+
Analysts